17.54

1.95% 0.335

After Hours: 17.54

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $17.54, with a volume of 201.09K. It is up +1.95% in the last 24 hours and down -5.90% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Previous Close:

$17.20

Open:

$17.19

24h Volume:

201.09K

Relative Volume:

0.88

Market Cap:

$1.08B

Revenue:

Net Income/Loss:

$-42.21M

P/E Ratio:

-14.38

EPS:

-1.22

Net Cash Flow:

$-33.16M

1W Performance:

+1.27%

1M Performance:

-5.90%

6M Performance:

+101.38%

1Y Performance:

+335.24%

1-Day Range:

$17.19

$18.72

1-Week Range:

$16.67

$18.72

52-Week Range:

$3.78

$22.69

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1190)

Industry

Medical Instruments & Supplies (58)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-08-12

Latest SEC Filings

PLSE's Discussions on Twitter

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Sep 24, 2024

Bank of New York Mellon Corp Buys 9,639 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 24, 2024

Sep 23, 2024

Metric Deep Dive: Understanding Pulse Biosciences Inc (PLSE) Through its Ratios - The Dwinnex

Sep 23, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - Defense World

Sep 23, 2024

Sep 22, 2024

Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 22, 2024

Sep 21, 2024

Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat

Sep 21, 2024

Pulse Biosciences (NASDAQ:PLSE) Upgraded to “Sell” at StockNews.com - Defense World

Sep 21, 2024

Sep 18, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - Defense World

Sep 18, 2024

Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 18, 2024

Sep 17, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - MarketBeat

Sep 17, 2024

Sep 15, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - Defense World

Sep 15, 2024

Sep 13, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - MarketBeat

Sep 13, 2024

Sep 11, 2024

Keeping an Eye on Pulse Biosciences Inc (PLSE) After Insider Trading Activity - Knox Daily

Sep 11, 2024

Sep 10, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7% - MarketBeat

Sep 10, 2024

Sep 09, 2024

Paul LaViolette Joins Pulse Bioscience's Board Of Directors - MPO-mag

Sep 09, 2024

Sep 03, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading Down 9.6% - MarketBeat

Sep 03, 2024

Sep 02, 2024